Company CellaVision AB

Equities

CEVI

SE0000683484

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for CellaVision AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - Nasdaq Stockholm Other stock markets 11:29:51 2024-04-24 am EDT			5-day change	1st Jan Change
240 ^SEK	+0.42%		+9.84%	+13.21%

Feb. 07	Transcript : CellaVision AB, Q4 2023 Earnings Call, Feb 07, 2024
Feb. 07	CellaVision AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision ABâs product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

SEK in Million	2022	Weight	2023	Weight	Delta
Instruments 56.2 %	357	55.9 %	380	56.2 %	+6.43%
Software and Other 24.9 %	182	28.5 %	169	24.9 %	-7.24%
Reagents 18.9 %	100	15.6 %	128	18.9 %	+28.20%

SEK in Million	2022	Weight	2023	Weight	Delta
United States 41.4 %	-	-	280	41.4 %	-
France 20.6 %	-	-	140	20.6 %	-
APAC 12.8 %	79	12.3 %	87	12.8 %	+9.96%
EMEA 11.3 %	280	43.8 %	77	11.3 %	-72.56%
Germany 9.0 %	-	-	61	9.0 %	-
Americas 4.9 %	280	43.8 %	33	4.9 %	-88.27%

Managers	Title	Age	Since
Lars Christer Fedrik Fåhraeus FOU	Founder	59	94-11-15
Simon Ostergaard CEO	Chief Executive Officer	53	21-03-20
Magnus Blixt DFI	Director of Finance/CFO	58	13-05-01
Kent Stråhlen BRD	Director/Board Member	56	00-08-31
Adele Horn IRC	Investor Relations Contact	-	-
Jeppe Brandstrup PRN	Corporate Officer/Principal	40	15-12-31
Peter Wilson SAM	Sales & Marketing	57	99-12-31
Urban Strindlöv SAM	Sales & Marketing	60	21-12-31
Adam Morell PRN	Corporate Officer/Principal	48	05-12-31

Members of the board	Title	Age	Since
Lars Christer Fedrik Fåhraeus FOU	Founder	59	94-11-15
Lotta Jarleryd BRD	Director/Board Member	58	22-05-10
Mikael Worning CHM	Chairman	62	20-04-22
Stefan Wolf BRD	Director/Board Member	60	18-05-03
Kent Stråhlen BRD	Director/Board Member	56	00-08-31
Louise Armstrong-Denby BRD	Director/Board Member	52	22-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	23,851,547	14,779,149 ( 61.96 %)	0	61.96 %

Name	Equities	%	Valuation
William Demant Invest A/S 19.93 %	4,752,999	19.93 %	106 M kr
Grenlunden CEVI AB 10.02 %	2,391,000	10.02 %	53 M kr
SEB Investment Management AB 8.383 %	1,999,436	8.383 %	45 M kr
Lars Christer Fedrik Fåhraeus 7.246 %	1,728,399	7.246 %	39 M kr
Swedbank Robur Fonder AB 5.714 %	1,362,776	5.714 %	30 M kr
Invesco Advisers, Inc. 4.618 %	1,101,561	4.618 %	25 M kr
Sjätte AP-fonden 2.531 %	603,774	2.531 %	13 M kr
AMF Fonder AB 2.330 %	555,784	2.330 %	12 M kr
Raiffeisen Kapitalanlage-Gesellschaft mbH 1.706 %	406,992	1.706 %	9 M kr
Länsförsäkringar Fondförvaltning AB 1.454 %	346,758	1.454 %	8 M kr

CellaVision AB

Mobilvägen 12

223 62, Lund

+46 4 64 60 16 00

http://www.cellavision.com

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

239 SEK

Average target price

257.5 SEK

Spread / Average Target

+7.74%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
CELLAVISION AB	+13.21%	527M
SARTORIUS AG	-12.06%	19.32B
QUIDELORTHO CORPORATION	-46.35%	2.7B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+16.10%	1.83B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.24%	1.63B
BIOTAGE AB	+20.19%	1.2B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.52%	896M
REVENIO GROUP OYJ	-8.03%	726M
VAREX IMAGING CORPORATION	-15.17%	701M
PHC CO.,LTD.	-.--%	302M

Medical Diagnostic & Testing Equipment